180 related articles for article (PubMed ID: 30572738)
1. Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
Carrasco-Garcia E; Álvarez-Satta M; García-Puga M; Ribeiro ML; Arevalo S; Arauzo-Bravo M; Matheu A
Expert Opin Ther Targets; 2019 Feb; 23(2):143-152. PubMed ID: 30572738
[TBL] [Abstract][Full Text] [Related]
2. Expression and Clinical Relevance of SOX9 in Gastric Cancer.
Mesquita P; Freire AF; Lopes N; Gomes R; Azevedo D; Barros R; Pereira B; Cavadas B; Pópulo H; Boaventura P; David L; Pereira L; Almeida R
Dis Markers; 2019; 2019():8267021. PubMed ID: 31275454
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
5. Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches.
Fu Y; Du P; Zhao J; Hu C; Qin Y; Huang G
Yonsei Med J; 2018 Dec; 59(10):1150-1158. PubMed ID: 30450848
[TBL] [Abstract][Full Text] [Related]
6. The stabilization of yes-associated protein by TGFβ-activated kinase 1 regulates the self-renewal and oncogenesis of gastric cancer stem cells.
Wang G; Sun Q; Zhu H; Bi Y; Zhu H; Xu A
J Cell Mol Med; 2021 Jul; 25(14):6584-6601. PubMed ID: 34075691
[TBL] [Abstract][Full Text] [Related]
7. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
[TBL] [Abstract][Full Text] [Related]
8. SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression.
Santos JC; Carrasco-Garcia E; Garcia-Puga M; Aldaz P; Montes M; Fernandez-Reyes M; de Oliveira CC; Lawrie CH; Araúzo-Bravo MJ; Ribeiro ML; Matheu A
Cancer Res; 2016 Nov; 76(22):6735-6746. PubMed ID: 27569216
[TBL] [Abstract][Full Text] [Related]
9. SOX9: An emerging driving factor from cancer progression to drug resistance.
Panda M; Tripathi SK; Biswal BK
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188517. PubMed ID: 33524528
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
[TBL] [Abstract][Full Text] [Related]
11. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
[TBL] [Abstract][Full Text] [Related]
13. SOX9: The master regulator of cell fate in breast cancer.
Jana S; Madhu Krishna B; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
Biochem Pharmacol; 2020 Apr; 174():113789. PubMed ID: 31911091
[TBL] [Abstract][Full Text] [Related]
14. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma.
Luo W; Nagaria TS; Sun H; Ma J; Lombardo JL; Bassett R; Cao AC; Tan D
Pathol Oncol Res; 2022; 28():1610293. PubMed ID: 35221802
[TBL] [Abstract][Full Text] [Related]
15. SOX9 promotes tumor progression through the axis BMI1-p21
Aldaz P; Otaegi-Ugartemendia M; Saenz-Antoñanzas A; Garcia-Puga M; Moreno-Valladares M; Flores JM; Gerovska D; Arauzo-Bravo MJ; Samprón N; Matheu A; Carrasco-Garcia E
Sci Rep; 2020 Jan; 10(1):357. PubMed ID: 31941916
[TBL] [Abstract][Full Text] [Related]
16. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
17. A detailed understanding of the COL10A1 and SOX9 genes interaction based on potentially damaging mutations in gastric cancer using computational techniques.
Aktas SH; Taskin-Tok T; Al-Khafaji K; Akın-Balı DF
J Biomol Struct Dyn; 2022; 40(22):11533-11544. PubMed ID: 34380365
[TBL] [Abstract][Full Text] [Related]
18. SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
Voronkova MA; Luanpitpong S; Rojanasakul LW; Castranova V; Dinu CZ; Riedel H; Rojanasakul Y
Sci Rep; 2017 Sep; 7(1):11653. PubMed ID: 28912540
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.
Ye T; Yang M; Huang D; Wang X; Xue B; Tian N; Xu X; Bao L; Hu H; Lv T; Huang Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):55. PubMed ID: 30728051
[TBL] [Abstract][Full Text] [Related]
20. SOX9/FXYD3/Src Axis Is Critical for ER
Xue Y; Lai L; Lian W; Tu X; Zhou J; Dong P; Su D; Wang X; Cao X; Chen Y; Wang Q
Mol Cancer Res; 2019 Jan; 17(1):238-249. PubMed ID: 30206184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
